These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 22626693

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Levetiracetam Clinical Pharmacokinetic Monitoring in Pediatric Patients with Epilepsy.
    Tan J, Paquette V, Levine M, Ensom MHH.
    Clin Pharmacokinet; 2017 Nov; 56(11):1267-1285. PubMed ID: 28353057
    [Abstract] [Full Text] [Related]

  • 28. Continuation rates of levetiracetam in children from the EULEVp cohort study.
    Dureau-Pournin C, Pédespan JM, Droz-Perroteau C, Lavernhe G, Mann M, Pollet C, Robinson P, Jové J, Moore N, Fourrier-Réglat A, EULEV study group.
    Eur J Paediatr Neurol; 2014 Jan; 18(1):19-24. PubMed ID: 24035600
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Population Pharmacokinetic Modeling of Levetiracetam in Pediatric and Adult Patients With Epilepsy by Using Routinely Monitored Data.
    Ito S, Yano I, Hashi S, Tsuda M, Sugimoto M, Yonezawa A, Ikeda A, Matsubara K.
    Ther Drug Monit; 2016 Jun; 38(3):371-8. PubMed ID: 26913593
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Levetiracetam: a long-term follow-up study of efficacy and safety.
    Bauer J, Ben-Menachem E, Krämer G, Fryze W, Da Silva S, Kasteleijn-Nolst Trenité DG.
    Acta Neurol Scand; 2006 Sep; 114(3):169-76. PubMed ID: 16911344
    [Abstract] [Full Text] [Related]

  • 34. Levetiracetam therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs.
    Contin M, Albani F, Riva R, Baruzzi A.
    Ther Drug Monit; 2004 Aug; 26(4):375-9. PubMed ID: 15257066
    [Abstract] [Full Text] [Related]

  • 35. The risk of paradoxical levetiracetam effect is increased in mentally retarded patients.
    Szucs A, Clemens Z, Jakus R, Rásonyi G, Fabó D, Holló A, Barcs G, Kelemen A, Janszky J.
    Epilepsia; 2008 Jul; 49(7):1174-9. PubMed ID: 18479387
    [Abstract] [Full Text] [Related]

  • 36. Levetiracetam as an adjunct to phenobarbital treatment in cats with suspected idiopathic epilepsy.
    Bailey KS, Dewey CW, Boothe DM, Barone G, Kortz GD.
    J Am Vet Med Assoc; 2008 Mar 15; 232(6):867-72. PubMed ID: 18341442
    [Abstract] [Full Text] [Related]

  • 37. High-dose intravenous levetiracetam for acute seizure exacerbation in children with intractable epilepsy.
    Depositario-Cabacar DT, Peters JM, Pong AW, Roth J, Rotenberg A, Riviello JJ, Takeoka M.
    Epilepsia; 2010 Jul 15; 51(7):1319-22. PubMed ID: 20163437
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Effect of levetiracetam on the pharmacokinetics of adjunctive antiepileptic drugs: a pooled analysis of data from randomized clinical trials.
    Gidal BE, Baltès E, Otoul C, Perucca E.
    Epilepsy Res; 2005 Jul 15; 64(1-2):1-11. PubMed ID: 15823510
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.